Free shipping on all orders over $ 500

Empagliflozin

Cat. No. M2667

All AbMole products are for research use only, cannot be used for human consumption.

Empagliflozin  Structure
Synonym:

BI 10773

Size Price Availability Quantity
10mM*1mL in DMSO USD 45  USD45 In stock
5mg USD 40  USD40 In stock
10mg USD 55  USD55 In stock
100mg USD 95  USD95 In stock
200mg USD 120  USD120 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Empagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >300-fold selectivity over SGLT-1, 4, 5 and 6.

Protocol (for reference only)
Cell Experiment
Cell lines HK-2 cells
Preparation method Cellular Apoptotic Assay
In the terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay, HK-2 cells incubated for 24 h in the presence or absence of empagliflozin were fixed in 4% paraformaldehyde and treated with a blocking solution (10% FBS in PBS) for 30 min at 25 °C. Cells were permeabilized with 0.1% (v/v) Triton X-100 in PBS, followed by incubation with the TUNEL reaction mixture for 1 h at 37 °C. After the treatment, the cells were observed under a fluorescence microscope.
Concentrations 100 and 500 nM
Incubation time 24 h
Animal Experiment
Animal models Male C57BL/6J mice (10 weeks of age)
Formulation dissolved in hydroxy ethyl cellulose (HEC)
Dosages 3 or 10 mg/kg
Administration oral gavage
Chemical Information
Molecular Weight 450.91
Formula C23H27ClO7
CAS Number 864070-44-0
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Wen-Chin Lee, et al. Cells. Empagliflozin Protects HK-2 Cells from High Glucose-Mediated Injuries via a Mitochondrial Mechanism

[2] Mizuno M, et al. Physiol Rep. Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.

[3] Sam Tsz Wai Cheng, et al. PLoS One. The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes

Related SGLT Products
Velagliflozin 

Velagliflozin is an orally available sodium-glucose cotransporter 2 (SGLT2) inhibitor, with anti-diabetic activity.

Tianagliflozin

Tianagliflozin is an SGLT2 inhibitor that may be used in studies related to type 2 diabetes.

JTT-662

JTT-662 is an SGLT1 inhibitor that can be used in studies related to type 2 diabetes.

JP-2266

JP-2266 is a dual SGLT1/2 inhibitor that can be used in studies related to diabetes.

Tofogliflozin

Tofogliflozin(CSG-452) is a potent and highly specific sodium/glucose cotransporter 2(SGLT2) inhibitor with Ki values of 2.9, 14.9, and 6.4 nM for human, rat, and mouse SGLT2.

  Catalog
Abmole Inhibitor Catalog




Keywords: Empagliflozin , BI 10773 supplier, SGLT, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.